HotSheets 2011 January February March April May June July August September October November December January | Newsletter | Cover Letter Us TOO Board Welcomes New Member FDA Approves Xgeva® (denosumab) to Help Prevent Cancer-Related Bone Injury US Panel Backs Provenge® for Medicare FDA Panel Rejects Prostate Drugs (Avodart® & Proscar®) for Prostate Cancer Prevention Could a Prostate Cancer Treatment Raise Colon Cancer Risk? Clinical Staging for Prostate Cancer Can’t Predict Likelihood for Recurrence Long-Term Effect of Early Postoperative Pelvic Floor Biofeedback on Continence post-RP Ask Doctor Snuffy Myers Doc Moyad’s “No Bogus Science” Column – “Can dogs really smell prostate cancer in urine?” Doctor Chodak’s Bottom Line Prostate Biopsies Are Not Associated with Increased Mortality DHT May Not Affect Prostate Size But May Reduce Bone Mineral Density Read more.. February | Newsletter | Cover Letter Special Burning Issues Supplement: A Systems Pathology Approach to Post-Surgical Patients with Anxiety Dutasteride Enhances the Predictive Usefulness of PSA As a Screening Test Is Prostate Cancer in Older Men More Deadly? Us TOO Names New Board Officers, Another Member for 2011 Popular Online Prostate Cancer Tool Questioned Cancer Blood Test Closer to Market Older Men Get Less Effective Cancer Care Decision Making in Localized Prostate Cancer: Lessons Learned from an Online Support Group Ask Doctor Snuffy Myers Doc Moyad’s “No Bogus Science” Column – Creatine Supplements ADT May Be Tied to Cataracts Doctor Chodak’s Bottom Line Read more.. March | Newsletter | Cover Letter Us TOO 2009 Annual Report Now Available Focusing on the Stress of Prostate Cancer Gene Test May Spot Lethal Prostate Tumors First 5-Year Outcomes Published on CyberKnife Radiosurgery for Prostate Cancer Improving Active Surveillance Outcome Using Stringent Enrollment Criteria Surgery vs. Radiation for High-Risk Disease Multidisciplinary vs. 1-on-1 Medical Care Prostate Cancer Support Groups, Health Literacy & Consumerism PSA & Confirmatory Biopsy in Surveillance Cancer Death Rates in African Americans Still High Timely Intervention with Zoledronic Acid Beneficial Ask Doctor Snuffy Myers Doc Moyad’s “No Bogus Science” Column – “IOM Barely Changes Vitamin D Recommendations” Doctor Chodak’s Bottom Line Read more.. April | Newsletter | Cover Letter Study Knocks Diagnostic Value of PSA Velocity Imaging Misses Mark in Prostate Cancer Large Study Shows Little Need for PSA Testing Beyond 10 Years Post-Surgery PSA Testing Declines a Bit Genetic Map of Prostate Cancer Cracked Disease-Free Survival Following Salvage Cryotherapy for Biopsy-Proven Radiotherapy-Recurrent Prostate Cancer Study Suggests Lower PSA Cutoff for Biopsy Ask Doctor Snuffy Myers Doc Moyad’s “No Bogus Science” Column – “Resistance Exercises vs. Calcium + Vitamin D” Doctor Chodak’s Bottom Line Drug (Abiraterone) Works in Most Prostate Cancer Subgroups Read more.. May | Newsletter | Cover Letter 20% Rise in Number of Cancer Survivors PSA Screening Is Higher in Men in Their 70s Short Course of ADT Works Well with RT Statins + RT More Effective in Prostate Cancer New Cancer Drug Heads to Clinical Trials Phase I/II Study of TRC105 in Refractory CRPC Digoxin Possible Treatment for Prostate Cancer? NCCN Continues to Modify Guidelines Ask Doctor Snuffy Myers Doc Moyad’s “No Bogus Science” Column – “An aspirin a day may reduce the risk of cancer” Doctor Chodak’s Bottom Line How Prostate Cancer May Spread to Bone Read more.. June | Newsletter | Cover Letter FDA Approves Abiraterone Early Surgery or Watchful Waiting? Biopsy May Progress without PSA Changes Study Supports Watchful Waiting for Low-Risk Prostate Cancer Another Endothelin Blocker Fails Upgrade in Gleason Score Between Biopsies & Pathology Following Radical Prostatectomy Overtreatment of Men with Low-Risk Prostate Cancer and Significant Comorbidity Phase III Trial of Ipilimumab (NCT01057810) Supplements Don’t Prevent Prostate Cancer Ask Doctor Snuffy Myers Doc Moyad’s “No Bogus Science” Column – “Is Omega-3 in fish oil really bad for you?” Doctor Chodak’s Bottom Line Read more.. July | Newsletter | Cover Letter Alpharadin (222Radium Chloride) Improves Overall Survival in Men with Metastatic CRPC Early PSA Testing & Risk of Long-Term Death Surgery Works in Locally-Advanced Disease AS Update from the John Hopkins Experience Effect of Surgery Delay in Men Undergoing AS NADiA ProsVue – A New Prognostic Prostate Cancer Test (for Post-RP Patients) Exelixis Drug Shown to Control Solid Tumors Fusion of MRI and Prostate Ultrasound Intermittent Vs. Continuous ADT Circulating Tumor Cells Predict Drug Response Ask Doctor Snuffy Myers Doctor Chodak’s Bottom Line Doc Moyad’s “No Bogus Science” Column – “___ Dietary Supplement Fights/Kills Prostate Cancer? Should Doc Moyad Support It?” Read more.. August | Newsletter | Cover Letter Medicare Will Pay for Prostate Cancer Drug Long-Term Efficacy of the Phase 1-2 Study of MDV3100 in Advanced Prostate Cancer Patients Before and after Docetaxel Therapy New Resource Kit from Us TOO for Men with Advanced Prostate Cancer Potential Combinability of Custirsen with MDV3100 and Hsp90 Inhibitors to Enhance Anti-Tumor Activity Against Prostate Cancer Kyphon® Balloon Kyphoplasty for Treating Spinal Fractures in Prostate Cancer Patients Prostate Cancer in Men Less than 50 Years Old: A Comparison of Race and Outcomes Ask Doctor Snuffy Myers Doc Moyad’s “No Bogus Science” Column – “You want another reason to lose weight? How about free vitamin D?!” Doctor Chodak’s Bottom Line Hydrodissection in Nerve-Sparing Radical Prostatectomy Improves Postoperative Potency Read more.. September | Newsletter | Cover Letter Urine Test May Help Detect / Stratify Prostate Cancer For Some Prostate Cancer Patients, Combo Treatment Improved Survival Us TOO Names New Board Members for 2011 Robot Technology May Drive Up Prostate Surgeries Letter to the Editors New Patient Information Guide for CyberKnife Age Adjustment in Active Surveillance ADT & 11C-Choline Uptake in PET/CT Scans Bone Flare with Abiraterone Treatment Ask Doctor Snuffy Myers Doc Moyad’s “No Bogus Science” Column – “Some vegetables may reduce the risk of prostate cancer recurring after treatment” Doctor Chodak’s Bottom Line Read more.. October | Newsletter | Cover Letter ADT Does Not Increase Cardiovascular Risk Five Genes Liked to Aggressive Prostate Cancer VA Adds to List of Agent Orange-Exposed Ships Two Clusterin Studies Released Good Long-Term QOL after Brachytherapy Dendreon & a Diagnostic for Provenge? New Online Tool & Tips on Bone Health New Provenge Plant Opens in California Valvoline Supports Prostate Cancer Awareness Elastography Beats Ultrasound for Detection Ask Doctor Snuffy Myers Doc Moyad’s “No Bogus Science” Column – “Sage supplement may reduce hot flashes” ERG Unrelated to PSA Recurrence w/o ADT Doctor Chodak’s Bottom Line Read more.. November | Newsletter USPSTF Says PSA Test Does Not Save Lives FDA Approves Prolia for Treating Bone Loss in Men and Women on Hormone Ablation Erections after Prostate Treatment Predicted by Models Us TOO Seeks Board Member Applications Ask Doctor Snuffy Myers Call to Action – Comment on USPSTF’s Draft Recommendation Statement Against PSA-Based Screening for Prostate Cancer SEA Blue Prostate Walk Shines Despite Rain 2011 Us TOO University Opens Diaglogue With Support Group Leaders Doc Moyad’s “No Bogus Science” Column – 1) Vitamin E and Prostate Cancer Death; 2) What the USPSTF Should Have Stated Doctor Chodak’s Bottom Line Read more.. December | Newsletter Share Hope and Donate to Us TOO MDV3100 Trial Stopped as Survival Improved Top Doctors Support PSA Screening in Men Brachytherapy & Risk of a Second Cancer Antibiotic Change Before Prostate Biopsy Men with a Family History of Prostate Cancer Do Not Need More Aggressive Treatment ADT Duration & Risk of Prostate Cancer Death New NCI Trial for Taxotere-Resistance Cancer Quanterix PSA Test to Predict PSA Recurrence Ask Doctor Snuffy Myers [11C]choline PET-CT for Detecting Pelvic Nodes Doc Moyad’s “No Bogus Science” Column – “Metformin and Lifestyle Changes” Doctor Chodak’s Bottom Line RT + ADT Extends Life in Advanced Cancer Read more..